GL1X · GenesisL1 explorer

MolNFT v1 · #147642 · protein

Human xylosyltransferase 1 in complex with peptide qeeegsggpqgg

6EJD: “Human xylosyltransferase 1 in complex with peptide qeeegsggpqgg”. X-ray diffraction, 1 ligand (PO4), 4 pockets (best druggability 0.75). MolNFT v1 #147642 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6EJD
Type
protein
Length
702 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Xylosyltransferase 1; Protein ambp
EC
2.4.2.26
UniProt
Q86Y38, P02760
Ligands
PO4
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AXylosyltransferase 1 (EC 2.4.2.26)protein69330% helix, 25% strandQ86Y38
BProtein ambpprotein90% helix, 11% strandP02760

Ligands and binding sites

  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18050.750.7979PO4
24820.680.7946empty
31050.450.7921empty
41650.430.7523empty

Interfaces

1 interface between chains.

  • A–B · 615 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6EJD · Human Xylosyltransferase 1 in complex with peptide QEEEGSGGPQGG · the same entry in another collection · chain A against A, TM-score 1.00
  • Q86Y38 · AlphaFold monomer V2.0 prediction for xylosyltransferase 1 (Q86Y38) · a predicted model of the same protein · chain A against A, TM-score 1.00
  • P02760 · AlphaFold monomer V2.0 prediction for protein ambp (P02760) · a predicted model of the same protein · chain B against A, TM-score 0.35

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.